| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 07/04/2013 | WO2013098375A1 New azetidine derivatives, pharmaceutical compositions and uses thereof |
| 07/04/2013 | US20130172551 Process for Preparing Carbamolypyridone Derivatives and Intermediates |
| 07/04/2013 | US20130172343 Derivatives of 1H-isoindol-3-amine, 1H-iso-aza-indol-3amine, 3,4-dihydroisoquinolin-1-amine, and 1,4-dihydroisoquinolin-3-amine as Beta-secretase Inhibitors |
| 07/04/2013 | US20130172338 Oxygen linked pyrimidine derivatives |
| 07/04/2013 | US20130172335 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds |
| 07/04/2013 | US20130172328 Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors |
| 07/04/2013 | US20130172323 Pyridazinones as gpr119 agonists |
| 07/04/2013 | US20130172316 New azetidine derivatives, pharmaceutical compositions and uses thereof |
| 07/04/2013 | CA2861013A1 New azetidine derivatives, pharmaceutical compositions and uses thereof |
| 07/03/2013 | EP2610244A1 Indole compounds |
| 07/03/2013 | EP2609081A1 Sulfonylpiperazine derivatives that interact with glucokinase regulatory protein for the treatment of diabetes |
| 07/03/2013 | CN103189376A Herbicidally active ketosultams and diketopyridines |
| 07/03/2013 | CN103183684A Quinolone lactone compound, and preparation method and application thereof |
| 07/03/2013 | CN102020659B Preparation method of methylal penem intermediate |
| 07/02/2013 | US8476265 Compounds-801 |
| 07/02/2013 | US8476256 Diazonamide analogs |
| 07/02/2013 | CA2585847C Photochromic h-fused benzo[f]chromene derivatives |
| 07/02/2013 | CA2509419C Macrolides |
| 07/02/2013 | CA2504582C Drug delivery device comprising a bilayered polymeric coating having an inhibitor of the mamalian target of rapamycin incorporated into the first polymeric coating layer |
| 06/27/2013 | WO2013095039A1 Compound for an organic optoelectronic device, organic light-emitting element comprising same, and display device comprising the organic light-emitting element |
| 06/27/2013 | WO2013093849A1 Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives |
| 06/27/2013 | WO2013093493A1 Novel rapamycin analogue |
| 06/27/2013 | US20130165435 Tocotrienol derivatives and associated methods |
| 06/26/2013 | EP2606045A1 Oxadiazole inhibitors of leukotriene production |
| 06/26/2013 | EP2606032A2 Composition and methods for treating glioblastoma |
| 06/26/2013 | EP2605658A1 Spiroxazolidinone compounds |
| 06/26/2013 | CN103180319A Inhibitors of semicarabazide - sensitive amine oxidase |
| 06/26/2013 | CN103180314A Oxadiazole inhibitors of leukotriene production |
| 06/26/2013 | CN103180296A Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |
| 06/26/2013 | CN103172641A Heterocyclic amino and alkoxy-replaced quinazoline derivative and application thereof |
| 06/25/2013 | US8471025 Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt |
| 06/25/2013 | US8471004 Bicyclic compounds |
| 06/25/2013 | CA2551611C Thiazole derivatives for treating or preventing parkinson's disease |
| 06/20/2013 | WO2013087807A1 4-aryl imidazole derivatives as mglu5 positive allesteric modiulators |
| 06/20/2013 | WO2013087739A1 4-aryl imidazole derivatives as mglur5 positive allosteric modulators |
| 06/20/2013 | WO2013020164A9 Compounds for treating respiratory syncytial virus infections |
| 06/20/2013 | US20130158259 2-aminopyrimidine modulators of the histamine h4 receptor |
| 06/20/2013 | US20130158070 Conjugates of polyunsaturated fatty acids and amine-containing compounds and uses thereof |
| 06/20/2013 | US20130158051 Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 06/20/2013 | US20130158037 Compounds and methods for treating tuberculosis infection |
| 06/20/2013 | US20130158011 Novel compounds |
| 06/20/2013 | US20130158006 Aminopyrimidine derivatives as lrrk2 modulators |
| 06/20/2013 | US20130158004 Azetidine Derivatives |
| 06/20/2013 | US20130158003 Heteroaryl compounds and methods of use thereof |
| 06/20/2013 | US20130157999 Aminopyrimidine derivatives as lrrk2 modulators |
| 06/20/2013 | US20130157996 Trpm8 antagonists and their use in treatments |
| 06/19/2013 | EP2604597A1 Heterocyclic compound and use thereof |
| 06/19/2013 | EP2603512A1 Derivatives of 6, 7-dihydro-3h-oxazolo [3, 4-a]pyrazine-5, 8- dione |
| 06/18/2013 | US8466294 1-aza-3,7-dioxabicyclo[3.3.0]octane compounds and their use as pro-fragrances |
| 06/18/2013 | US8466289 Heterocyclic sulfonamide derivatives |
| 06/18/2013 | US8466143 Azepine derivatives as pharmaceutical agents |
| 06/18/2013 | CA2566898C Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
| 06/18/2013 | CA2566212C Heteroaryl-substituted cyclohexyl-1,4-diamine derivatives |
| 06/13/2013 | WO2013086229A1 Bicyclic aryl and heteroaryl sodium channel inhibitors |
| 06/13/2013 | WO2013083591A1 Substituted pyrazoles as mglu5 receptor modulators |
| 06/13/2013 | WO2013022238A3 Tricyclic glycosylated derivative compound, a production method therefor, and an immunosuppressant pharmaceutical composition comprising a tacrolimus glycosylation derivative |
| 06/13/2013 | US20130150378 Solid state forms of macrocyclic kinase inhibitors |
| 06/13/2013 | US20130150354 New selective ccr2 antagonists |
| 06/13/2013 | US20130150353 Fused Tricyclic Inhibitors of Mammalian Target of Rapamycin |
| 06/13/2013 | US20130150349 2,4-pyrimidinediamine compounds and their uses |
| 06/13/2013 | US20130150347 Novel compounds |
| 06/13/2013 | US20130150344 Heterocyclic compound |
| 06/13/2013 | US20130150342 Pyrrolopyrimidine compounds as inhibitors of cdk4/6 |
| 06/13/2013 | US20130150340 6-(4-Hydroxy-phenyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| 06/13/2013 | US20130150339 Bicyclic Aryl and Heteroaryl Sodium Channel Inhibitors |
| 06/13/2013 | US20130150329 2,4-Pyrimidinediamine Compounds and Prodrugs and Their Uses |
| 06/12/2013 | EP2602260A1 Process for preparing compound having hiv integrase inhibitory activity |
| 06/12/2013 | EP2601201A1 Process for preparation of novel 42-0-(heteroalkoxyalkyl) rapamycin compounds with anti-proliferative properties" |
| 06/12/2013 | EP2601197A1 Amino-iso-indole, amino-aza-iso-indole, amino-dihydroisoquinoline and amino-benzoxazine compounds as beta-secretase modulators and methods of use |
| 06/12/2013 | CN103154004A Process for preparing compound having HIV integrase inhibitory activity |
| 06/12/2013 | CN103153995A Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors |
| 06/12/2013 | CN103153957A N-pyridin-3-yl or N-pyrazin-2-yl carboxamides |
| 06/11/2013 | CA2730511C 4-phenoxymethylpiperidines as modulators of gpr119 activity |
| 06/06/2013 | WO2013082570A1 Tocotrienol derivatives and associated methods |
| 06/06/2013 | WO2013080156A1 3,7-disubstituted octahydro-2h-pyrido[4,3-e][1,3]oxazin-2-one antibiotics |
| 06/06/2013 | WO2013079494A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/06/2013 | WO2013079223A1 Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rorϒ, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune diseases |
| 06/06/2013 | US20130144061 Process for preparing a compound by a novel sandmeyer-like reaction using a nitroxide radical compound as a reaction catalyst |
| 06/06/2013 | US20130143927 Compounds that modulate intracellular calcium |
| 06/06/2013 | US20130143896 Isoxazolo-quinazolines as modulators of protein kinase activity |
| 06/06/2013 | US20130143864 (6,7-dihydro-2-nitro-5h-imidazol[2,1-b][1,3]oxazin-6yl) amide compounds, preparation methods and uses thereof |
| 06/06/2013 | US20130142807 Compositions and methods for inhibition of the jak pathway |
| 06/06/2013 | CA2857694A1 Peptide deformylase inhibitors |
| 06/06/2013 | CA2856946A1 Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rory, nr1f3) activity and for the treatment of chronic inflammatory and autoimmunediseases |
| 06/06/2013 | CA2854266A1 3,7-disubstituted octahydro-2h-pyrido[4,3-e][1,3]oxazin-2-one antibiotics |
| 06/06/2013 | CA2850593A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/05/2013 | EP2598508A1 Isoxazolo-quinazolines as modulators of protein kinase activity |
| 06/05/2013 | CN103140494A Process for preparation of novel 42-0-(heteroalkoxyalkyl) rapamycin compounds with anti-proliferative properties |
| 06/05/2013 | CN103130792A 2-aminothiazoles compound |
| 06/05/2013 | CN102083832B Spiro (piperidine-4,2'-pyrrolidine)-1-(3,5-trifluoromethyl phenyl) methylcarboxamides as NK1 Tachikynin receptor antagonists |
| 06/05/2013 | CN101616592B 3-substituted-[1,2,3]-benzotriazinone compound for enhancing glutamatergic synaptic responses |
| 06/04/2013 | US8455659 Method for manufacturing neuraminic acid derivatives |
| 06/04/2013 | US8455510 Rapamycin carbonic ester analogues, pharmaceutical compositions, preparations and uses thereof |
| 06/04/2013 | US8455483 Compounds—801 |
| 06/04/2013 | US8455482 Substituted pyrrolidine derivative |
| 06/04/2013 | CA2545660C Heterocyclic inhibitors of mek and methods of use thereof |
| 06/04/2013 | CA2545659C Bicyclic inhibitors of mek |
| 05/30/2013 | US20130137685 2,5,7-substituted oxazolopyrimidine derivatives |
| 05/30/2013 | US20130137675 Heterocyclic compound and use thereof |
| 05/30/2013 | US20130136794 Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof |